The Advisory Council on the Misuse of Drugs is reviewing the evidence of drug use in LGBT+ communities and in the context of chemsex in the UK. It welcomes evidence from as broad a spectrum of participants as possible, with a deadline of 30 January 2026. The ACMD will use this evidence to assist in formulating advice to government.


